Measurement of free PSA in the diagnosis and staging of prostate cancer

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 756-759

  Morote, Juan ^b   Raventós, Carles X ^a   Lorente, José A ^a   Lopez Pacios, Miguel A ^a   Encabo, Gloria ^a   De Torres, Inés ^a   Andreu, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

BIOPSY; BLOOD PROTEINS; HUMANS; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEIN BINDING;

EID: 0031001158     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<756::AID-IJC11>3.0.CO;2-6     Document Type: Article

References (16)

1. ARCANGELI, C.G., SHEPHERD, L., SMITH, D.S., HUMPHREY, P.A., KEETH, D.W. and CATALONA, W.J., Correlation of percent free PSA with pathologic features of prostatic carcinoma. J. Urol., 155, 420A (1996).
2. BANGMA, C.H., KRANSE, R., BLIJENBERG, B.G. and SCHRÖDER, F.H., The value of screening tests in the detection of prostate cancer. Part I: results of a retrospective evaluation of 1726 men. Urology, 46, 773-778 (1995a).
3. BANGMA, C.H., KRANSE, R., BLIJENBERG, B.G. and SCHRÖDER, F.H., The value of screening tests in the detection of prostate cancer. Part II: retrospective analysis of free/total prostate-specific-antigen ratio, age-specific reference ranges and PSA density. Urology, 46, 779-784 (1995b).
4. CATALONA, W.J. and 12 OTHERS, Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151, 1283-1290 (1994).
5. CATALONA, W.J., SMITH, D.S., WOLFERT, R.L., WANG, T.J., RITTENHOUSE, H.G., RATLIF, T.L. and NADLER, R.B., Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate-cancer screening. J. Amer. med. Ass., 274, 1214-1220 (1995).
6. CHRISTENSSON, A., BJÖRK, T., NILSSON, O., DAHLÉN, U., MATIKAINEN, M., COCKETT, A., ABRAHAMSSON, P. and LILJA, H., Serum prostate-specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150, 100-105 (1993).
7. FILELLA, X., ALCOVER, J., MOLINA, R., GIMENEZ, N., RODRIGUEZ, A., JO, J., CARRETERO, P. and BALLESTA, A., Clinical usefulness of free PSA fraction as an indicator of prostate cancer. Int. J. Cancer, 63, 780-784 (1995).
8. GRAEFEN, M., HAMMERER, P., HENKE, P., HILZ, H., HULAND, E. and HULAND, H., Percentage of free PSA does not correlate with pathological outcome. J. Urol., 155, 237A (1996).
9. HENRICKS, W.H., ENGLAND, B.G., GIACHERIO, D.A., OESTERLING, J.E. and WOJNO, K.J., Free-to-total-PSA ratio does not predict extra-prostatic spread of prostatic adenocarcinoma. J. Urol., 155, 236A (1996).
10. LERNER, S.E. and 12 OTHERS, Free, complexed, and total serum prostate-specific-antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic-acid ploidy in patients with adenocarcinoma of prostate. Urology, 48, 240-248 (1996)
11. LILJA, H., CHRISTENSSON, A., DAHLÉN, U., MATIKAINEN, M., NILSSON, O., PETTERSSON, J. and LÖVGREN, T., Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin. Chem., 37, 1619-1625 (1991).
12. OESTERLING, J.E. Prostate-specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145, 907-923 (1991).
13. OESTERLING, J.E. and 12 OTHERS, Determination of the reflex range and appropriate outpoints for percent free PSA in 413 men referred for prostate evaluation using the Axym system. J. Urol., 155, 448A (1996).
14. PARTIN, A.W., SUBONG, E.N., JONES, K.A., MURSCHKE, P.L., EPSTEIN, J.I., CHAN, D.W., CARTER, H.B. and LUDERER, A.A., Free-to-total PSA does not improve the prediction of final pathological stage for men with localized prostate cancer. J. Urol., 155, 419A (1996).
15. SMITH, D.S., CATALONA, W.J. and KEETCH, D.W., Comparison of percent free PSA and PSA density as methods to enhance the specificity of PSA. J. Urol., 155, 445A (1996).
16. WOLFF, J.M., BORCHERS, H., EFFERT, P.J., HABIB, F.K., and JAKSE, G., Free-to-total prostate-specific-antigen serum concentration in patients with prostate cancer and beninc prostatio hyperplasia. Brit. J. Urol., 78, 409-413 (1996).